Juvenile rats directly exposed to dapagliflozin showed a risk to the developing kidney (renal pelvic and tubular dilatations) during maturation
Contact your healthcare provider if: The bad taste is severe, persistent, or significantly affecting your quality of life, nutrition, or ability to take the medication as prescribed You experience taste changes accompanied by other concerning symptoms such as severe nausea, persistent vomiting, signs of dehydration, abdominal pain, or difficulty swallowing You notice signs of oral infection, including painful sores, white patches in your mouth, swollen or bleeding gums, or fever The taste disturbance is accompanied by symptoms that might suggest gastroesophageal reflux disease (GERD), such as heartburn, chest discomfort, or regurgitation of food You develop new neurological symptoms alongside taste changes, such as facial numbness, difficulty speaking, or changes in smell perception, which could indicate conditions requiring urgent evaluation Seek immediate medical attention and stop taking semaglutide if you experience: Severe, persistent abdominal pain, sometimes radiating to the back, which could indicate pancreatitis Right upper abdominal pain, fever, or yellowing of skin/eyes, which might suggest gallbladder disease Severe vomiting, inability to keep fluids down, dizziness, or reduced urination, which could indicate dehydration or kidney problems Your healthcare provider may: Conduct a thorough oral examination or refer you to a dentist to rule out dental causes Review your complete medication list to identify potential drug interactions or other medications that might contribute to dysgeusia Order laboratory tests to check for nutritional deficiencies (such as zinc or vitamin B12) or assess kidney and liver function Evaluate for gastroesophageal reflux and consider treatment if indicated Assess whether dose adjustment or temporary discontinuation of semaglutide is appropriate Consider whether the benefits of continuing semaglutide outweigh the discomfort from taste changes, or discuss alternative treatment options Except in the emergency situations noted above, do not adjust your dose or discontinue semaglutide without medical guidance, as this may lead to worsening glycemic control in patients with diabetes or weight regain in those using it for weight management
Programs in this space typically prescribe GLP-1 receptor agonists such as semaglutide, or the dual agonist tirzepatide, either as FDA-approved brand products or compounded preparations
10.3389/fphar.2013.00156 40 HaraY.WakamoriM.IshiiM.MaenoE.NishidaM.YoshidaT.et al
It also reduces oxidative stress and boosts the effectiveness of other key nutrients in the IV, like Vitamin C and zinc
